Yconfirmed NAFLD and 21 healthy control subjects, aged 20 years, who attended Yokohama

Yconfirmed NAFLD and 21 healthy control subjects, aged 20 years, who attended Yokohama City University between April 2007 and March 2012. We obtained written informed consent from all 10781694 subjects before conducting examinations. The study was conformed to the ethical guidelines of the Declaration of Helsinki and approved by the Ethics Committee at Yokohama City University. Subjects with a history of excessive alcohol consumption (weekly consumption .140 g for men, .70 g for women), other liver diseases, use of drugs associated with fatty liver, and clinically significant weight loss, for example, were excluded. Twenty-one healthy subjects with a mean age and sex ratio similar to those of the NAFLD group were also enrolled. Liver enzyme levels and ultrasound scans were normal for all of the healthy subjects. For the purpose of this study, subjects diagnosed with diabetes mellitus before the present admission and subjects with fasting plasma glucose .126 mg/dl and/or serum HbA1c .6.1 were defined as having diabetes mellitus. Subjects taking antidyslipidemic drugs and subjects with cholesterol .220 mg/dl and/or triglyceride .150 mg/dl were defined as having dyslipidemia. Subjects using antihypertensive drugs and subjects with resting blood pressure exceeding 130/85 mmHg on at least two occasions were defined as having hypertension.Clinical and MedChemExpress Eliglustat Laboratory EvaluationsBody weight and height were measured with a calibrated scale after the subjects had removed their shoes and any heavy clothing. Venous blood samples were obtained after an overnight (12 h) fast and were used to measure serum glucose, aspartate aminotransferase (AST), alanine aminotransferase (ALT), CRP, ferritin, and insulin. Serum insulin levels were measured using a radioimmuRNA Isolation and Real-Time PCR AnalysisTotal RNA was extracted from liver tissue samples from patients with NAFLD (n = 70) using the RNeasy mini kit (QIAGEN, Tokyo, Japan). The mRNA expression levels of human CD14 and b-actin were determined in liver tissue by fluorescence-based RT-PCR on an ABI PRISM 7700 Sequence Detection System (Life Technologies, Carlsbad, CA).sCD14 and Liver Inflammation in NASHCell CultureThe murine monocyte/macrophage cell line RAW264.7 was obtained from ATCC (Rockville, MD). Cells were cultured at 37uC under 5 CO2 in Dulbecco’s modified Eagle’s medium (ASAHI TECHNO GLASS Co., Tokyo, Japan), and supplemented with 100 units/mL penicillin and 100 mg/mL streptomycin plus 10 fetal bovine serum. After incubation, the medium was treated with LPS (10 ng/mL) in PBS for 2 or 4 h. PBS supernatants were recovered, treated with protease inhibitor mixture (Sigma-Aldrich), and centrifuged at 10,000 x g for 10 min, following the analysis of sCD14 in the culture medium using by a Western immunoblot analysis and a sandwich enzymelinked immunosorbent assay. Proteins were incubated with antimouse CD14 antibodies (BD Pharmingen), and HRP-conjugated secondary antibody (Cell Signaling Technology).Statistical AnalysisContinuous variables are summarized as means 6 standard deviation, while categorical variables are summarized as percentages. Spearman’s correlation 13655-52-2 coefficient was used to determine the correlations between serum sCD14 levels and the factors of interest. The t-test was used for univariate comparisons between groups of subjects. Because many of the variables were not normally distributed, we used the Kruskal allis test for comparisons of more than two independent groups. We assessed the dia.Yconfirmed NAFLD and 21 healthy control subjects, aged 20 years, who attended Yokohama City University between April 2007 and March 2012. We obtained written informed consent from all 10781694 subjects before conducting examinations. The study was conformed to the ethical guidelines of the Declaration of Helsinki and approved by the Ethics Committee at Yokohama City University. Subjects with a history of excessive alcohol consumption (weekly consumption .140 g for men, .70 g for women), other liver diseases, use of drugs associated with fatty liver, and clinically significant weight loss, for example, were excluded. Twenty-one healthy subjects with a mean age and sex ratio similar to those of the NAFLD group were also enrolled. Liver enzyme levels and ultrasound scans were normal for all of the healthy subjects. For the purpose of this study, subjects diagnosed with diabetes mellitus before the present admission and subjects with fasting plasma glucose .126 mg/dl and/or serum HbA1c .6.1 were defined as having diabetes mellitus. Subjects taking antidyslipidemic drugs and subjects with cholesterol .220 mg/dl and/or triglyceride .150 mg/dl were defined as having dyslipidemia. Subjects using antihypertensive drugs and subjects with resting blood pressure exceeding 130/85 mmHg on at least two occasions were defined as having hypertension.Clinical and Laboratory EvaluationsBody weight and height were measured with a calibrated scale after the subjects had removed their shoes and any heavy clothing. Venous blood samples were obtained after an overnight (12 h) fast and were used to measure serum glucose, aspartate aminotransferase (AST), alanine aminotransferase (ALT), CRP, ferritin, and insulin. Serum insulin levels were measured using a radioimmuRNA Isolation and Real-Time PCR AnalysisTotal RNA was extracted from liver tissue samples from patients with NAFLD (n = 70) using the RNeasy mini kit (QIAGEN, Tokyo, Japan). The mRNA expression levels of human CD14 and b-actin were determined in liver tissue by fluorescence-based RT-PCR on an ABI PRISM 7700 Sequence Detection System (Life Technologies, Carlsbad, CA).sCD14 and Liver Inflammation in NASHCell CultureThe murine monocyte/macrophage cell line RAW264.7 was obtained from ATCC (Rockville, MD). Cells were cultured at 37uC under 5 CO2 in Dulbecco’s modified Eagle’s medium (ASAHI TECHNO GLASS Co., Tokyo, Japan), and supplemented with 100 units/mL penicillin and 100 mg/mL streptomycin plus 10 fetal bovine serum. After incubation, the medium was treated with LPS (10 ng/mL) in PBS for 2 or 4 h. PBS supernatants were recovered, treated with protease inhibitor mixture (Sigma-Aldrich), and centrifuged at 10,000 x g for 10 min, following the analysis of sCD14 in the culture medium using by a Western immunoblot analysis and a sandwich enzymelinked immunosorbent assay. Proteins were incubated with antimouse CD14 antibodies (BD Pharmingen), and HRP-conjugated secondary antibody (Cell Signaling Technology).Statistical AnalysisContinuous variables are summarized as means 6 standard deviation, while categorical variables are summarized as percentages. Spearman’s correlation coefficient was used to determine the correlations between serum sCD14 levels and the factors of interest. The t-test was used for univariate comparisons between groups of subjects. Because many of the variables were not normally distributed, we used the Kruskal allis test for comparisons of more than two independent groups. We assessed the dia.